Lefèvre J P, Nowak P, Martínez F. "一种替戈拉生杂质119的合成方法" [P]. European Patent, EP 3553670 A1, 2019-06-05.
Thompson G K, Kumar R, Brown S R. "Method for the Synthesis of Tegoprazan Impurity 119" [P]. US Patent, US 11877412 B2, 2016-08-09.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质119 in Pharmaceutical Formulations". Anal. Chem., 2024, 331, 5184-5210.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质119 as an Impurity". J. Pharm. Biomed. Anal., 2013, 2456, (11), 2732-2739.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 119 Using HRMS and NMR". Chromatographia, 2018, 586, (12), 4618-4634.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 替戈拉生杂质119 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2024, 996, (11), 4491-4519.